BostonGene, a leading provider of AI-driven molecular and immune profiling solutions, announced a collaboration with BeiGene Ltd., a global oncology company that intends to change its name to BeOne ...

Joe Lennerz, MD, PhD, Chief Scientific Officer to Present on Machine-Driven Genomics and High-Complexity Testing for Transforming Precision Oncology BostonGene ... authors to report on investments ...

January 22, 2025--(BUSINESS WIRE)--BostonGene, a leading provider of AI-driven molecular and immune profiling solutions, announced its participation in The Festival of Genomics & Biodata 2025 ...

WALTHAM, Mass., January 28, 2025--(BUSINESS WIRE)--BostonGene, a leading provider of AI-driven molecular and immune profiling solutions, announced its participation in the Friends of Cancer ...

WALTHAM, Mass.--(BUSINESS WIRE)--BostonGene, a leading provider of AI-driven molecular and immune profiling solutions, today announced a collaboration with BeiGene Ltd., a global oncology company ...